Avidity of onconeural antibodies is of clinical relevance.
Totland C, Ying M, Haugen M, Mazengia K, Storstein A, Aarseth J, Martinez A, Vedeler C.
Totland C, et al. Among authors: vedeler c.
Cancer Immunol Immunother. 2013 Aug;62(8):1393-6. doi: 10.1007/s00262-013-1442-6. Epub 2013 Jun 4.
Cancer Immunol Immunother. 2013.
PMID: 23733227
Free PMC article.